In the Autumn Newsletter of The UCLH Leukaemia & Lymhoma Unit charity, there was a feature article on the PhD student, Eva, who is sponsored by Lauren's Fund.
Eva's research project is called "Developing an anti-CD33 chimeric antigen receptor for acute myeloid leukaemia adoptive T cell therapy". She explains how her research aims to develop a cancer treatment which is much more effective and less toxic than current treatments, like chemotherapy. It was great to read an update from Eva and we wish her every success in our quest to beat leukaemia!
Eva's research project is called "Developing an anti-CD33 chimeric antigen receptor for acute myeloid leukaemia adoptive T cell therapy". She explains how her research aims to develop a cancer treatment which is much more effective and less toxic than current treatments, like chemotherapy. It was great to read an update from Eva and we wish her every success in our quest to beat leukaemia!
The full edition of the Wardlines Newsletter can be viewed here.
No comments:
Post a Comment